The study design was to monitor the epigenetic changes in two tumor suppressor genes, RUNX3 and PRSS8, and follow up with a screening for epigenetic changes in more tumor suppressor genes if CSE-induced changes were to be observed in the RUNX3 and PRSS8 marker genes. This evidence concerns the gene RUNX3 and neoplasm.